Article3 Biotech2018
Article in 3 Biotech, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 37 citations in OpenAlex.
- Article
- Contrasted Ethnobotanical and Literature Knowledge of Anti-Mosquito Plants from Guadeloupe.Biology · 2025Article
- Silver Nanoparticles as a Potent Nanopesticide: Toxic Effects and Action Mechanisms on Pest Insects of Agricultural Importance-A Review.Molecules (Basel, Switzerland) · 2024Review
- Potential ectoparasiticide for dog and cat fleas, a combination ofJournal of advanced veterinary and animal research · 2024Article
- Review
- Phytochemical Composition and Bioassay on IranianJournal of arthropod-borne diseases · 2022Article
- Green Nano-Biotechnology: A New Sustainable Paradigm to Control Dengue Infection.Bioinorganic chemistry and applications · 2022Review
- Rhamnolipids and essential oils in the control of mosquito-borne tropical diseases.Applied microbiology and biotechnology · 2021Article
- Article
- Dengue Fever: Therapeutic Potential ofFrontiers in pharmacology · 2021Review
- Biogenic nanoparticles: a comprehensive perspective in synthesis, characterization, application and its challenges.Journal, genetic engineering & biotechnology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study manifests the larvicidal efficacy of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.